Pharmaceutical outsourcing services provider PCI Pharma Services (PCI) has announced its plans to acquire Melbourne-based company Pharmaceutical Packaging Professionals (PPP).
The acquisition of PPP, a provider of clinical trial manufacturing, packaging, storage and distribution services, will establish a presence for PCI in Australia as it continues to grow and expand in the Asia Pacific region.
Australia is one of the leading countries for Phase 1 studies globally, according to PCI.
With the acquisition, PPP’s Phase I offering also enables PCI to better support customers from early phases of clinical development through to commercial launch.
PPP's services include early clinical phase sterile and non-sterile drug manufacture of investigational medicines, packaging and labeling services for investigational products, as well as logistical services including storage and distribution to global investigational sites.
PPP is currently undertaking a facility expansion and upgrade to add additional storage and distribution services, labeling and packaging rooms, Grade D manufacturing as well as sterile-fill manufacturing capabilities for Phase II clinical studies.
PPP’s services complement PCI’s global portfolio of clinical and commercial services, including clinical and commercial scale drug manufacturing, packaging and labeling of clinical trial medicines, global logistical services to investigational sites and commercial contract packaging services.
